Welcome to JDD Corner, your gateway to a world of dermatology knowledge and insights! JDD Corner is a curated collection of video abstracts, editor picks, Key Opinion Leader (KOL) spotlights, trending articles, and much more. Whether you are a dermatologist, a skincare enthusiast, or simply curious about the latest advancements in dermatology, JDD Corner is your one-stop destination for staying informed and up-to-date with the most exciting developments in the field. Explore our carefully selected content and immerse yourself in the dynamic world of dermatology. Welcome to JDD Corner!
JDD Corner
JDD Corner
Video Abstracts
Introducing an Exciting NEW Opportunity for Our Authors to Connect with Our Readership through a Cutting-Edge Media Channel! Email us at editorial@jddonline.com to get started!
NEW! VIDEO ABSTRACT
Clinical Evaluation of a Thiamidol-Based Regimen With SPF Compared With SPF Alone for Facial Hyperpigmentation
Hyperpigmentation disorders are common skin concerns that negatively impact patient quality of life and self-perception. Hyperpigmentation results from the overproduction of melanin via a multi-step process with a rate-limiting step catalyzed by tyrosinase.
NEW! VIDEO ABSTRACT
Molecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis
Seborrheic dermatitis(SD) is a chronic inflammatory skin disease that affects sebaceous areas, typically the face and scalp, with an estimated prevalence of 2% to 5%. It is thought to result from a combination of immune dysregulation, barrier dysfunction, and colonization with Malassezia species.1,2
NEW! VIDEO ABSTRACT
Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation
Cutaneous hyperpigmentation, which includes melasma, post-inflammatory hyperpigmentation, and solar lentigines, significantly impacts patients’ quality of life.
NEW! VIDEO ABSTRACT
Retrospective Review of Dermal Safety Studies of Organic Sunscreens
Sunscreens can reduce skin cancer and sunburn. Recent studies on dermal penetration have raised concerns about the safety of sunscreens with organic ultraviolet (UV) filters.
NEW! VIDEO ABSTRACT
Perceptions and Recommendations for Sunscreen: A Cross-Sectional Survey of United States Dermatology Healthcare Providers
The dermatology HCPs in this survey strongly support sunscreen use and believe that FDA-approved sunscreens are effective and safe. The social media findings highlight a continued need to improve education on sunscreen use and increase counseling from clinicians on sun protection behaviors.
NEW! VIDEO ABSTRACT
Open-Label Study: Over-the-Counter Oat Flour/Oat Oil/ Oat Extract-containing Lotion With Avenanthramides for Sensitive Skin and Psoriasis
Psoriasis is a common skin condition that affects the physical and emotional well-being of patients. Moisturizers have been shown to significantly improve skin condition and quality of life in this patient population. Skin afflictions such as atopic dermatitis and pruritis share etiological similarities with psoriasis, and oatmeal (Avena sativa)-containing lotion has proven effective in treating the symptoms of those conditions. However, data on the use of an over-the-counter oatmeal-containing lotion alone to treat the symptoms of psoriasis are limited.
Author Spotlight
Our current Author Spotlight features Brooke Bartley MD, one of the co-authors of Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel, published in our May 2026 issue. In addition to his article, Dr. Bartley provided his insight about the current state of dermatology and how the field is adapting to new advances in technology and treatments.
Read More
Trending Articles
Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel
Cutaneous squamous cell carcinoma (cSCC) represents a significant clinical challenge in patients with locally advanced (laCSCC) or metastatic (mCSCC) disease who are not candidates for surgery or radiation. In addition to PD-1 inhibitors, pembrolizumab and cemiplimab, cosibelimab, a PD-L1 inhibitor, has been recently approved by the US Food and Drug Administration (FDA) for laCSCC and mCSCC. Given its recent approval, practical guidance is needed to support clinician decision-making regarding cosibelimab’s efficacy and safety.
Read More
The Emerging Role of Metformin in Skin Cancer: Mechanistic and Clinical Insights
Metformin, widely used for type 2 diabetes mellitus, has demonstrated antitumor effects through modulation of metabolic and immune pathways. This review explores its potential role in the prevention and treatment of skin cancers, including melanoma and nonmelanoma skin cancers (NMSCs).
Read More
Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study
Melasma is an acquired pigmentary disorder characterized by symmetrical hyperpigmented macules and patches on sun-exposed areas, primarily the face. Kligman’s formula, or “triple combination cream,” is widely used but has potential side effects. Metformin, an oral anti-diabetic agent, possesses anti-inflammatory and anti-oxidative properties, suggesting its possible role in melasma treatment. This study aims to compare the efficacy and safety of topical Metformin with Kligman’s formula in melasma treatment through a split-face design study.
Read More
Dermatologists’ Practices and Perspectives on Human Papillomavirus, Surgical Plume, and Cancer Risk
This is the first study to examine HPV vaccination rates, protective equipment use, and self-reported health outcomes among dermatologic surgeons in the context of surgical plume exposure. Dermatologists routinely perform electrocautery and laser procedures that generate a surgical plume–a bioaerosol containing toxic chemicals, cellular debris, and viral particles such as human papillomavirus (HPV) DNA.1,2
Read More
Pembrolizumab as an Off-Label Treatment of Facial Angiosarcoma: A Case Report
We report an atypical case of cutaneous angiosarcoma presenting as unilateral nasal swelling in an elderly male. The lesion was unresponsive to topical and antibiotic therapy. Diagnosis was confirmed after surgical excision, and disease control was ultimately achieved through radiation and off-label use of pembrolizumab.
Read More
Beyond Efficacy: 0.6% Selenium Disulfide Shampoo Matches 2% Ketoconazole for Seborrheic Dermatitis with Superior Cosmesis
Although most dandruff shampoos are effective, many leave hair dry and unmanageable, potentially impacting patient compliance and treatment outcomes.
Read More
Recent News
Editor's Picks
Video Pearls
Tough Day at the Office: Lupus, Sarcoidosis, and a Side of Morphea
Watch as Dr. Friedman shares basic principles to managing three distinct diseases – cutaneous lupus, sarcoidosis and linear morphea. Learn why you need to do a good review of organ systems and be prepared to phone a friend (or more) across the aisle in medicine.
Tips for Providing Better Atopic Dermatitis Care
With the growing list of therapeutic options, Dr. Friedman encourages clinicians to go back to the basics and address one of the greatest challenges — treatment adherence.
Acne and Diet
Adam Friedman, professor and chair of dermatology at GW School of Medicine and Health Sciences. Dr. Friedman says acne is an evidence-based example of the saying “you are what you eat.”
Crushing It In The Capital: Lessons From Residency Translated
Dr. Friedman provides his tips for remaining calm during the craziest of office visits. He also shares why being fun, creative and an off-label bandit matters.
New Innovations in Hyperpigmentation
Dr. Chilukuri outlines at-home and in-office treatments to address hyperpigmentation, including newly developed therapies.
